B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MPHOSPH8

MOLECULAR TARGET

M-phase phosphoprotein 8

UniProt: Q99549NCBI Gene: 5473724 compounds

MPHOSPH8 (M-phase phosphoprotein 8) is targeted by 24 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MPHOSPH8

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1myricetin-3-O-galactopyranoside [Supplementary Concept]1.102
2Aurintricarboxylic Acid1.102
3Cisplatin1.102
4Nitroprusside1.102
5Quercetin0.691
6Methotrexate0.691
7daph0.691
8Dequalinium0.691
9Diamide0.691
10Disulfiram0.691
11Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as0.691
12Fluspirilene0.691
13Idarubicin0.691
14Iodoacetamide0.691
15Levodopa0.691
16Methyldopa0.691
17Nicardipine0.691
18Perphenazine0.691
19piceatannol0.691
20Promethazine0.691
21Reserpine0.691
22Thioridazine0.691
23trequinsin hydrochloride0.691
24tyrphostin 90.691

About MPHOSPH8 as a Drug Target

MPHOSPH8 (M-phase phosphoprotein 8) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 24 compounds with documented MPHOSPH8 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MPHOSPH8 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.